Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 1/20 | 0.43 |
| ▸ | CASP1 | P29466 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.34 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.34 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.34 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.34 |
| ▸ | MLYCD | O95822 | 2/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | DRD2 | P14416 | 1/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.33 |
| ▸ | DRD3 | P35462 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL11043956 | 0.81 | ALDH1A1 (0.44) | CASP1ALDH1A1MAPTHPGDDRD2 | |
| SCHEMBL109552 | 0.81 | — | — | |
| Hydrochloric Acid SCHEMBL10492582 | 0.78 | — | — | |
| SCHEMBL19874572 | 0.78 | — | — | |
| SCHEMBL14098259 | 0.74 | CASP1 (0.54) | CASP1ALDH1A1MAPTHPGDMLYCD | |
| SCHEMBL2558000 | 0.74 | ALDH1A1 (0.54) | CASP1ALDH1A1MAPTHPGDCHRM2 | |
| SCHEMBL4375620 | 0.74 | — | — | |
| Propionic Acid SCHEMBL3410291 | 0.74 | FFAR3 (0.56) | FFAR3MAPTCHRM2CHRM4CHRM5 | |
| SCHEMBL11143514 | 0.74 | ALDH1A1 (0.37) | CASP1ALDH1A1MAPTHPGDTSHR | |
| Propionic Acid SCHEMBL5320043 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9815001-B2 | Use of a fiber conduit contactor for extraction | Chemtor, LP. (US) | 2017-11-14 | — | — | US | disclosed |
| US-20170014733-A1 | Use Of A Fiber Conduit Contactor For Extraction | MASSINGILL, DR. JOHN | 2017-01-19 | — | — | US | disclosed |
| US-9468866-B2 | Use of a fiber conduit contactor for metal and/or metalloid extraction | CHEMTOR, LP (US) | 2016-10-18 | — | — | US | disclosed |
| WO-2014047195-A1 | USE OF A FIBER CONDUIT CONTACTOR FOR METAL AND/OR METALLOID EXTRACTION | CHEMTOR, LP (US) | 2014-03-27 | — | — | WO | disclosed |
| US-20140076805-A1 | Use of a Fiber Conduit Contactor for Metal and/or Metalloid Extraction | CHEMTOR, LP (US) | 2014-03-20 | — | — | US | disclosed |
| CN-102199442-B | Method for applying amine proton-type ionic liquid extractant in desulfurization of oil product and recovering extractant | UNIV DALIAN | 2013-11-06 | — | — | CN | disclosed |
| CN-102199442-A | Method for applying amine proton-type ionic liquid extractant in desulfurization of oil product and recovering extractant | UNIV DALIAN | 2011-09-28 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170014733-A1 | Use Of A Fiber Conduit Contactor For Extraction | SORD, NEFM, FGF2 | FFAR3 1428/4885CASP1 1798/4885ALDH1A1 368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.